The 5 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +0.60% increase from the last price of 14.91.
The current consensus among 5 polled investment analysts is to Hold stock in Aveo Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.06
Reporting Date Mar 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.